Comment 2 |
Antimicrobial use — getting it right and
keeping it safe 2
By Jonathan Cooke, PhD, MRPharmS
Hospital Pharmacist 2008;15:2
Full Text PDF (30K) |
| Top |
News and research update 3-6 |
News summary 3-6
Hospital Pharmacist 2008;15:3-6
Headlines PDF (80K)
-Pharmacy
teams join forces after fire at Royal Marsden
-Medicines reconciliation guidance
-Norovirus causes over 100 ward closures across the UK
-SSRIs might interact with methyl blue
-PPIs are overprescribed in the NHS, say experts
-New guidance on biopharmaceuticals
-New vaccine target to fight pandemic flu
-Pregnant women need vitamin D supplements
|
| Top |
Special feature: Healthcare-associated
infection 7-18 |
Life-long learning
Healthcare-associated infection — Hospital-acquired infection 7-12
Healthcare-associated infections represent a massive
challenge currently facing the NHS. Pharmacists must play their part in the management
of infected patients and be aware of strategies that prevent one infection becoming
an outbreak
Hospital Pharmacist 2008;15:7-12
Summary PDF (60K)
Healthcare-associated infection — Intervention-related infection 13-15
Invasive medical procedures break the body’s
defence against infection and facilitate infiltration by micro-organisms. This
article describes these infections
and the financial burden they create
for the health services
Hospital Pharmacist 2008;15:13-15
Summary PDF (50K)
Healthcare-associated infection — Home intravenous therapy 16-18
Home IV therapy is becoming more common in the UK.
It reduces a patient’s exposure to hospital-acquired infections and has
a number of other benefits. This article describes the management of these patients
and the role of the homecare team
Hospital Pharmacist 2008;15:16-18
Summary PDF (60K) |
| Top |
Careers 23-24 |
Careers
Proactive risk reduction — by a gastroenterology pharmacist 23-24
By Joyeta Das, MRPharmS, ClinDip and Katy Morris, MRPharmS, ClinDip
Patients who suffer from inflammatory bowel disease
are often prescribed high risk, immunosuppressant medicines. This article describes
a pharmacy-led service to help reduce the risk associated with these drugs and
improve patient safety
Hospital Pharmacist 2008;15:23-24
Full
Text PDF (50K) |
| Top |
Meetings 25-27 |
American Society of Health-system Pharmacists
Sharing recent advances in hospital pharmacy practice 25-27
Progress in gene therapy, biologics and cytotoxic risk monitoring was discussed at the recent ASHP midyear clinical meeting. Laurence Goldberg, Christine Clark and Hannah Pike report
Hospital Pharmacist 2008;15:25-27
Full Text PDF (80K) |
| Top |
Focus on technicians 28 |
Focus on technicians
Clinical training for technicians 28
Extended roles for technicians are fundamental to
developing the pharmacy profession, but require additional training. One technician
shares her experience of completing a certificate in psychiatric therapeutics
Hospital Pharmacist 2008;15:28
Full Text PDF (30K) |
| Top |
Life-long learning 29-30 |
Life-long learning
QUESTIONS: Healthcare-associated infection 30
Hospital Pharmacist 2008;15:30
PDF (40K)
ANSWERS: Urological emergencies 29
Hospital Pharmacist 2008;15:29
Full text |
| Top |